Angiotensin Converting Enzyme Inhibitors Market - Global Outlook and Forecast 2021-2027

April 2021 | 91 pages | ID: A6A408EA1A90EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Angiotensin Converting Enzyme Inhibitors in Global, including the following market information:

Global Angiotensin Converting Enzyme Inhibitors Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global top five companies in 2020 (%)

The global Angiotensin Converting Enzyme Inhibitors market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Angiotensin Converting Enzyme Inhibitors companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Angiotensin Converting Enzyme Inhibitors Market, By Type, 2016-2021, 2022-2027 ($ millions)

Global Angiotensin Converting Enzyme Inhibitors Market Segment Percentages, By Type, 2020 (%)

• Benazepril (Lotensin)
• Captopril
• Enalapril (Vasotec)
• Fosinopril
• Lisinopril (Prinivil, Zestril)
• Moexipril
• Perindopril
• Quinapril (Accupril)
• Ramipril (Altace)
• Trandolapril

China Angiotensin Converting Enzyme Inhibitors Market, By Application, 2016-2021, 2022-2027 ($ millions)

China Angiotensin Converting Enzyme Inhibitors Market Segment Percentages, By Application, 2020 (%)

• Coronary Artery Disease
• Heart Failure
• Diabetes
• Chronic Kidney Diseases
• Heart Attacks
• Scleroderma
• Migraines
• Others

Global Angiotensin Converting Enzyme Inhibitors Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)

Global Angiotensin Converting Enzyme Inhibitors Market Segment Percentages, By Region and Country, 2020 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Total Angiotensin Converting Enzyme Inhibitors Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)

Total Angiotensin Converting Enzyme Inhibitors Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:

• Pfizer
• AstraZeneca
• Novartis AG
• Daiichi Sankyo, Inc
• Sanofi
• Merck
• Abbott

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Human Interferons Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Human Interferons Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL HUMAN INTERFERONS OVERALL MARKET SIZE

2.1 Global Human Interferons Market Size: 2021 VS 2027
2.2 Global Human Interferons Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Human Interferons Sales (Consumption): 2016-2027

3 COMPANY LANDSCAPE

3.1 Top Human Interferons Players in Global Market
3.2 Top Global Human Interferons Companies Ranked by Revenue
3.3 Global Human Interferons Revenue by Companies
3.4 Global Human Interferons Sales by Companies
3.5 Global Human Interferons Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Human Interferons Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Human Interferons Product Type
3.8 Tier 1, Tier 2 and Tier 3 Human Interferons Players in Global Market
  3.8.1 List of Global Tier 1 Human Interferons Companies
  3.8.2 List of Global Tier 2 and Tier 3 Human Interferons Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Human Interferons Market Size Markets, 2021 & 2027
  4.1.2 Interferon-alpha
  4.1.3 Interferon-beta
  4.1.4 Interferon-gamma
4.2 By Type - Global Human Interferons Revenue & Forecasts
  4.2.1 By Type - Global Human Interferons Revenue, 2016-2021
  4.2.2 By Type - Global Human Interferons Revenue, 2022-2027
  4.2.3 By Type - Global Human Interferons Revenue Market Share, 2016-2027
4.3 By Type - Global Human Interferons Sales & Forecasts
  4.3.1 By Type - Global Human Interferons Sales, 2016-2021
  4.3.2 By Type - Global Human Interferons Sales, 2022-2027
  4.3.3 By Type - Global Human Interferons Sales Market Share, 2016-2027
4.4 By Type - Global Human Interferons Price (Manufacturers Selling Prices), 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Human Interferons Market Size, 2021 & 2027
  5.1.2 Hepatitis
  5.1.3 Herpes
  5.1.4 Pneumonia
  5.1.5 Others
5.2 By Application - Global Human Interferons Revenue & Forecasts
  5.2.1 By Application - Global Human Interferons Revenue, 2016-2021
  5.2.2 By Application - Global Human Interferons Revenue, 2022-2027
  5.2.3 By Application - Global Human Interferons Revenue Market Share, 2016-2027
5.3 By Application - Global Human Interferons Sales & Forecasts
  5.3.1 By Application - Global Human Interferons Sales, 2016-2021
  5.3.2 By Application - Global Human Interferons Sales, 2022-2027
  5.3.3 By Application - Global Human Interferons Sales Market Share, 2016-2027
5.4 By Application - Global Human Interferons Price (Manufacturers Selling Prices), 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Human Interferons Market Size, 2021 & 2027
6.2 By Region - Global Human Interferons Revenue & Forecasts
  6.2.1 By Region - Global Human Interferons Revenue, 2016-2021
  6.2.2 By Region - Global Human Interferons Revenue, 2022-2027
  6.2.3 By Region - Global Human Interferons Revenue Market Share, 2016-2027
6.3 By Region - Global Human Interferons Sales & Forecasts
  6.3.1 By Region - Global Human Interferons Sales, 2016-2021
  6.3.2 By Region - Global Human Interferons Sales, 2022-2027
  6.3.3 By Region - Global Human Interferons Sales Market Share, 2016-2027
6.4 North America
  6.4.1 By Country - North America Human Interferons Revenue, 2016-2027
  6.4.2 By Country - North America Human Interferons Sales, 2016-2027
  6.4.3 US Human Interferons Market Size, 2016-2027
  6.4.4 Canada Human Interferons Market Size, 2016-2027
  6.4.5 Mexico Human Interferons Market Size, 2016-2027
6.5 Europe
  6.5.1 By Country - Europe Human Interferons Revenue, 2016-2027
  6.5.2 By Country - Europe Human Interferons Sales, 2016-2027
  6.5.3 Germany Human Interferons Market Size, 2016-2027
  6.5.4 France Human Interferons Market Size, 2016-2027
  6.5.5 U.K. Human Interferons Market Size, 2016-2027
  6.5.6 Italy Human Interferons Market Size, 2016-2027
  6.5.7 Russia Human Interferons Market Size, 2016-2027
  6.5.8 Nordic Countries Human Interferons Market Size, 2016-2027
  6.5.9 Benelux Human Interferons Market Size, 2016-2027
6.6 Asia
  6.6.1 By Region - Asia Human Interferons Revenue, 2016-2027
  6.6.2 By Region - Asia Human Interferons Sales, 2016-2027
  6.6.3 China Human Interferons Market Size, 2016-2027
  6.6.4 Japan Human Interferons Market Size, 2016-2027
  6.6.5 South Korea Human Interferons Market Size, 2016-2027
  6.6.6 Southeast Asia Human Interferons Market Size, 2016-2027
  6.6.7 India Human Interferons Market Size, 2016-2027
6.7 South America
  6.7.1 By Country - South America Human Interferons Revenue, 2016-2027
  6.7.2 By Country - South America Human Interferons Sales, 2016-2027
  6.7.3 Brazil Human Interferons Market Size, 2016-2027
  6.7.4 Argentina Human Interferons Market Size, 2016-2027
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Human Interferons Revenue, 2016-2027
  6.8.2 By Country - Middle East & Africa Human Interferons Sales, 2016-2027
  6.8.3 Turkey Human Interferons Market Size, 2016-2027
  6.8.4 Israel Human Interferons Market Size, 2016-2027
  6.8.5 Saudi Arabia Human Interferons Market Size, 2016-2027
  6.8.6 UAE Human Interferons Market Size, 2016-2027

7 MANUFACTURERS & BRANDS PROFILES

7.1 Roche
  7.1.1 Roche Corporate Summary
  7.1.2 Roche Business Overview
  7.1.3 Roche Human Interferons Major Product Offerings
  7.1.4 Roche Human Interferons Sales and Revenue in Global (2016-2021)
  7.1.5 Roche Key News
7.2 Anke Biotechnology
  7.2.1 Anke Biotechnology Corporate Summary
  7.2.2 Anke Biotechnology Business Overview
  7.2.3 Anke Biotechnology Human Interferons Major Product Offerings
  7.2.4 Anke Biotechnology Human Interferons Sales and Revenue in Global (2016-2021)
  7.2.5 Anke Biotechnology Key News
7.3 Bayer
  7.3.1 Bayer Corporate Summary
  7.3.2 Bayer Business Overview
  7.3.3 Bayer Human Interferons Major Product Offerings
  7.3.4 Bayer Human Interferons Sales and Revenue in Global (2016-2021)
  7.3.5 Bayer Key News
7.4 Merck
  7.4.1 Merck Corporate Summary
  7.4.2 Merck Business Overview
  7.4.3 Merck Human Interferons Major Product Offerings
  7.4.4 Merck Human Interferons Sales and Revenue in Global (2016-2021)
  7.4.5 Merck Key News
7.5 Tri-Prime
  7.5.1 Tri-Prime Corporate Summary
  7.5.2 Tri-Prime Business Overview
  7.5.3 Tri-Prime Human Interferons Major Product Offerings
  7.5.4 Tri-Prime Human Interferons Sales and Revenue in Global (2016-2021)
  7.5.5 Tri-Prime Key News
7.6 Kawin
  7.6.1 Kawin Corporate Summary
  7.6.2 Kawin Business Overview
  7.6.3 Kawin Human Interferons Major Product Offerings
  7.6.4 Kawin Human Interferons Sales and Revenue in Global (2016-2021)
  7.6.5 Kawin Key News
7.7 Genzon Pharma
  7.7.1 Genzon Pharma Corporate Summary
  7.7.2 Genzon Pharma Business Overview
  7.7.3 Genzon Pharma Human Interferons Major Product Offerings
  7.4.4 Genzon Pharma Human Interferons Sales and Revenue in Global (2016-2021)
  7.7.5 Genzon Pharma Key News
7.8 Novartis
  7.8.1 Novartis Corporate Summary
  7.8.2 Novartis Business Overview
  7.8.3 Novartis Human Interferons Major Product Offerings
  7.8.4 Novartis Human Interferons Sales and Revenue in Global (2016-2021)
  7.8.5 Novartis Key News
7.9 Biogen
  7.9.1 Biogen Corporate Summary
  7.9.2 Biogen Business Overview
  7.9.3 Biogen Human Interferons Major Product Offerings
  7.9.4 Biogen Human Interferons Sales and Revenue in Global (2016-2021)
  7.9.5 Biogen Key News
7.10 Zydus Cadila
  7.10.1 Zydus Cadila Corporate Summary
  7.10.2 Zydus Cadila Business Overview
  7.10.3 Zydus Cadila Human Interferons Major Product Offerings
  7.10.4 Zydus Cadila Human Interferons Sales and Revenue in Global (2016-2021)
  7.10.5 Zydus Cadila Key News
7.11 Huaxin Biotechnology
  7.11.1 Huaxin Biotechnology Corporate Summary
  7.11.2 Huaxin Biotechnology Human Interferons Business Overview
  7.11.3 Huaxin Biotechnology Human Interferons Major Product Offerings
  7.11.4 Huaxin Biotechnology Human Interferons Sales and Revenue in Global (2016-2021)
  7.11.5 Huaxin Biotechnology Key News
7.12 Harbin Pharmaceutical
  7.12.1 Harbin Pharmaceutical Corporate Summary
  7.12.2 Harbin Pharmaceutical Human Interferons Business Overview
  7.12.3 Harbin Pharmaceutical Human Interferons Major Product Offerings
  7.12.4 Harbin Pharmaceutical Human Interferons Sales and Revenue in Global (2016-2021)
  7.12.5 Harbin Pharmaceutical Key News

8 GLOBAL HUMAN INTERFERONS PRODUCTION CAPACITY, ANALYSIS

8.1 Global Human Interferons Production Capacity, 2016-2027
8.2 Human Interferons Production Capacity of Key Manufacturers in Global Market
8.3 Global Human Interferons Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 HUMAN INTERFERONS SUPPLY CHAIN ANALYSIS

10.1 Human Interferons Industry Value Chain
10.2 Human Interferons Upstream Market
10.3 Human Interferons Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Human Interferons Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Angiotensin Converting Enzyme Inhibitors Market Opportunities & Trends in Global Market
Table 2. Angiotensin Converting Enzyme Inhibitors Market Drivers in Global Market
Table 3. Angiotensin Converting Enzyme Inhibitors Market Restraints in Global Market
Table 4. Key Players of Angiotensin Converting Enzyme Inhibitors in Global Market
Table 5. Top Angiotensin Converting Enzyme Inhibitors Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Angiotensin Converting Enzyme Inhibitors Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Angiotensin Converting Enzyme Inhibitors Revenue Share by Companies, 2016-2021
Table 8. Global Companies Angiotensin Converting Enzyme Inhibitors Product Type
Table 9. List of Global Tier 1 Angiotensin Converting Enzyme Inhibitors Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Angiotensin Converting Enzyme Inhibitors Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Angiotensin Converting Enzyme Inhibitors Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Angiotensin Converting Enzyme Inhibitors Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Angiotensin Converting Enzyme Inhibitors Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Angiotensin Converting Enzyme Inhibitors Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Angiotensin Converting Enzyme Inhibitors Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Angiotensin Converting Enzyme Inhibitors Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Angiotensin Converting Enzyme Inhibitors Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Angiotensin Converting Enzyme Inhibitors Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Angiotensin Converting Enzyme Inhibitors Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Angiotensin Converting Enzyme Inhibitors Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Angiotensin Converting Enzyme Inhibitors Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Angiotensin Converting Enzyme Inhibitors Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Angiotensin Converting Enzyme Inhibitors Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Angiotensin Converting Enzyme Inhibitors Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Angiotensin Converting Enzyme Inhibitors Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Angiotensin Converting Enzyme Inhibitors Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Angiotensin Converting Enzyme Inhibitors Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Angiotensin Converting Enzyme Inhibitors Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Angiotensin Converting Enzyme Inhibitors Revenue, (US$, Mn), 2022-2027
Table 30. Pfizer Corporate Summary
Table 31. Pfizer Angiotensin Converting Enzyme Inhibitors Product Offerings
Table 32. Pfizer Angiotensin Converting Enzyme Inhibitors Revenue (US$, Mn), (2016-2021)
Table 33. AstraZeneca Corporate Summary
Table 34. AstraZeneca Angiotensin Converting Enzyme Inhibitors Product Offerings
Table 35. AstraZeneca Angiotensin Converting Enzyme Inhibitors Revenue (US$, Mn), (2016-2021)
Table 36. Novartis AG Corporate Summary
Table 37. Novartis AG Angiotensin Converting Enzyme Inhibitors Product Offerings
Table 38. Novartis AG Angiotensin Converting Enzyme Inhibitors Revenue (US$, Mn), (2016-2021)
Table 39. Daiichi Sankyo, Inc Corporate Summary
Table 40. Daiichi Sankyo, Inc Angiotensin Converting Enzyme Inhibitors Product Offerings
Table 41. Daiichi Sankyo, Inc Angiotensin Converting Enzyme Inhibitors Revenue (US$, Mn), (2016-2021)
Table 42. Sanofi Corporate Summary
Table 43. Sanofi Angiotensin Converting Enzyme Inhibitors Product Offerings
Table 44. Sanofi Angiotensin Converting Enzyme Inhibitors Revenue (US$, Mn), (2016-2021)
Table 45. Merck Corporate Summary
Table 46. Merck Angiotensin Converting Enzyme Inhibitors Product Offerings
Table 47. Merck Angiotensin Converting Enzyme Inhibitors Revenue (US$, Mn), (2016-2021)
Table 48. Abbott Corporate Summary
Table 49. Abbott Angiotensin Converting Enzyme Inhibitors Product Offerings
Table 50. Abbott Angiotensin Converting Enzyme Inhibitors Revenue (US$, Mn), (2016-2021)

List Of Figures

LIST OF FIGURES

Figure 1. Angiotensin Converting Enzyme Inhibitors Segment by Type
Figure 2. Angiotensin Converting Enzyme Inhibitors Segment by Application
Figure 3. Global Angiotensin Converting Enzyme Inhibitors Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Angiotensin Converting Enzyme Inhibitors Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Angiotensin Converting Enzyme Inhibitors Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Angiotensin Converting Enzyme Inhibitors Revenue in 2020
Figure 8. By Type - Global Angiotensin Converting Enzyme Inhibitors Revenue Market Share, 2016-2027
Figure 9. By Application - Global Angiotensin Converting Enzyme Inhibitors Revenue Market Share, 2016-2027
Figure 10. By Region - Global Angiotensin Converting Enzyme Inhibitors Revenue Market Share, 2016-2027
Figure 11. By Country - North America Angiotensin Converting Enzyme Inhibitors Revenue Market Share, 2016-2027
Figure 12. US Angiotensin Converting Enzyme Inhibitors Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Angiotensin Converting Enzyme Inhibitors Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Angiotensin Converting Enzyme Inhibitors Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Angiotensin Converting Enzyme Inhibitors Revenue Market Share, 2016-2027
Figure 16. Germany Angiotensin Converting Enzyme Inhibitors Revenue, (US$, Mn), 2016-2027
Figure 17. France Angiotensin Converting Enzyme Inhibitors Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Angiotensin Converting Enzyme Inhibitors Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Angiotensin Converting Enzyme Inhibitors Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Angiotensin Converting Enzyme Inhibitors Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Angiotensin Converting Enzyme Inhibitors Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Angiotensin Converting Enzyme Inhibitors Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Angiotensin Converting Enzyme Inhibitors Revenue Market Share, 2016-2027
Figure 24. China Angiotensin Converting Enzyme Inhibitors Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Angiotensin Converting Enzyme Inhibitors Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Angiotensin Converting Enzyme Inhibitors Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Angiotensin Converting Enzyme Inhibitors Revenue, (US$, Mn), 2016-2027
Figure 28. India Angiotensin Converting Enzyme Inhibitors Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Angiotensin Converting Enzyme Inhibitors Revenue Market Share, 2016-2027
Figure 30. Brazil Angiotensin Converting Enzyme Inhibitors Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Angiotensin Converting Enzyme Inhibitors Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Angiotensin Converting Enzyme Inhibitors Revenue Market Share, 2016-2027
Figure 33. Turkey Angiotensin Converting Enzyme Inhibitors Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Angiotensin Converting Enzyme Inhibitors Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Angiotensin Converting Enzyme Inhibitors Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Angiotensin Converting Enzyme Inhibitors Revenue, (US$, Mn), 2016-2027
Figure 37. Pfizer Angiotensin Converting Enzyme Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. AstraZeneca Angiotensin Converting Enzyme Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Novartis AG Angiotensin Converting Enzyme Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Daiichi Sankyo, Inc Angiotensin Converting Enzyme Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Sanofi Angiotensin Converting Enzyme Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Merck Angiotensin Converting Enzyme Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2016-2021)